Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/216495
Title: | Health-related quality of life in long-term colorectal cancer survivors |
Author: | Marcos Delgado, Alba Martín Sánchez, Vicente Molina Barceló, Ana Alonso-Molero, Jéssica Pérez Gómez, Beatriz Aragonés, Nuria Ederra-Sanza, María Fernández-Tardón, Guillermo Binefa i Rodríguez, Gemma Moreno Aguado, Víctor Barrios-Rodríguez, Rocío Amiano, Pilar Pastor Teso, Enrique Alguacil, Juan Castaño-Vinyals, Gemma Kogevinas, Manolis Molina de la Torre, Antonio José Pollán, Marina Huerta Castaño, José María |
Keywords: | Qualitat de vida Càncer colorectal Mortalitat Quality of life Colorectal cancer Mortality |
Issue Date: | 25-Sep-2024 |
Publisher: | MDPI |
Abstract: | The aim of our study is to evaluate the relationship between sociodemographic and clinical characteristics of individuals with Colorectal Cancer (CRC), tumour-intrinsic characteristics and treatment received with health-related quality of life (HRQoL). Methods: Cross-sectional analysis of data from 805 survivors from the MCC study was conducted. HRQoL was assessed through a general and specific questionnaire, SF-12 and FCSI (Colorectal Symptom Index). Statistical analyses were performed with linear regression with adjustment for sociodemographic variables, stage at diagnosis and histological grade. Results: Participants had survived a median of 7.9 years from diagnosis (IQR 7.1-8.5 years). Age at diagnosis, sex and area showed a clear association with HRQoL in both physical and mental dimensions of the SF-12 questionnaire. A direct association between CRC recurrence was also found in the PCS-12 and MCS-12 dimensions and radical surgery in the PCS-12. Regarding the scores in FCSI questionnaire, statistically significant differences were observed by sex, age and area, with older women being the most impaired (p < 0.001). Conclusions: Age, sex and area was associated with lower scores of HRQoL among CRC survivors. Knowing the determinants related to HRQoL would allow us to lay the groundwork to develop strategies that help reduce morbidity and mortality, relapses and increase HRQoL. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/healthcare12191917 |
It is part of: | Healthcare, 2024, vol. 12, num.19 |
URI: | https://hdl.handle.net/2445/216495 |
Related resource: | https://doi.org/10.3390/healthcare12191917 |
ISSN: | 2227-9032 |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) Articles publicats en revistes (ISGlobal) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
870397.pdf | 651.55 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License